tiprankstipranks
C4 Therapeutics presents cemsidomide Phase 1 data at ASH
PremiumThe FlyC4 Therapeutics presents cemsidomide Phase 1 data at ASH
3M ago
C4 Therapeutics Appoints Steve Hoerter to Board
Premium
Company Announcements
C4 Therapeutics Appoints Steve Hoerter to Board
3M ago
C4 Therapeutics appoints Hoerter to board of directors
Premium
The Fly
C4 Therapeutics appoints Hoerter to board of directors
3M ago
C4 Therapeutics files to sell 4.87M shares of common stock for holders
PremiumThe FlyC4 Therapeutics files to sell 4.87M shares of common stock for holders
4M ago
C4 Therapeutics reports Q3 EPS (35c), consensus (38c)
Premium
The Fly
C4 Therapeutics reports Q3 EPS (35c), consensus (38c)
4M ago
C4 Therapeutics Appoints New Chief Scientific Officer
Premium
Company Announcements
C4 Therapeutics Appoints New Chief Scientific Officer
4M ago
C4 Therapeutics Announces Board Changes and Strategic Shift
PremiumCompany AnnouncementsC4 Therapeutics Announces Board Changes and Strategic Shift
6M ago
C4 Therapeutics appoints Stephen Fawell to board of directors
Premium
The Fly
C4 Therapeutics appoints Stephen Fawell to board of directors
6M ago
C4 Therapeutics expects cash to provide runway into 2027
Premium
The Fly
C4 Therapeutics expects cash to provide runway into 2027
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100